{
    "medicine_id": "2c06c925ae1a702f1499debcbdec5cd807d587b6",
    "platform_id": "DB05219",
    "metadata": {
        "name": "Eucrisa 20 mg 1g Ointment",
        "composition": "20 mg 1g Crisaborole",
        "clinical_particulars": {
            "therapeutic_indications": "Intended for the topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older",
            "contraindications": {
                "disease": "Hypersensitivity reactions such as contact urticaria may occur and discontinuation of the treatment is advised No evidence of mutagenic or clastrogenic potential as well as altered effects on fertility Oral LD50 value for rats is 500mg kg",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Crisaborole has broad spectrum anti inflammatory activity by mainly targeting phosphodiesterase 4 PDE4 enzyme that is a key regulator of inflammatory cytokine production As this enzyme is expressed in keratinocytes and immune cells crisaborole mediates an anti inflammatory effect on almost all inflammatory cells Topical application of this drug is useful as it potentiates the localization of this drug in the skin and this anti inflammatory activity is in the low micromolar range",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}